If you are not happy with the results below please do another search
The White House said on April 12 that it was prepared to send additional therapeutic treatments to the state of Michigan, which is experiencing a worrying number of Covid-19 cases, but declined to promise more vaccine as the state has sought.
Gilead Sciences Inc. said on April 12 that the company decided to stop a late-stage trial of the intravenous treatment Veklury in high-risk non-hospitalized patients with Covid-19.
Immunosuppressive drugs for inflammatory diseases like rheumatoid arthritis, multiple sclerosis and ulcerative colitis can impair the body’s response to the Covid-19 vaccines from Pfizer/BioNTech and Moderna, according to new data.
FCB Health Network president & CEO Dana Maiman on April 12 announced that Anna Loyeva joined Mosaic Group – the Network’s full-service payer and market-access healthcare agency – as management director.
Six months after a Covid-19 diagnosis, more than 33 percent of people exhibited some form of brain damage, according to a study appearing in Lancet Psychiatry.
Regeneron Pharmaceuticals announced results from the company’s Phase III trial of recently infected asymptomatic Covid-19 patients for the REGEN-COV (casirivimab with imdevimab) antibody cocktail.
AstraZeneca’s diabetes drug Farxiga (dapagliflozin) failed to reach endpoints in a Phase III study as a potential treatment for hospitalized Covid-19 patients at serious risk of developing complications.
Confusion and complacency in addressing Covid-19 means the pandemic is a long way from over, but it can be brought under control in months with proven public health measures, WHO Director-General Tedros Adhanom Ghebreyesus said on April 12.
Treating Covid-19 patients at home with a commonly used inhaled asthma drug called budesonide can speed up their recovery, according to UK trial results on April 12 which doctors said could change the way the disease is treated around the world.
Eli Lilly said on April 12 the company had a revised agreement with the U.S. government for the Covid-19 antibody drug bamlanivimab, which will now be sold in combination with another therapy.
